MC
PFE icon

Mirabaud & Cie’s Pfizer PFE Stock Holding History

Mirabaud & Cie’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,330
Closed -$275K – 62
2025
Q2 		$275K Sell
11,330
-1,449
-11% -$33.8K 0.09% 56
2025
Q1 		$324K Buy
12,779
+1,150
+10% +$30.1K 0.11% 51
2024
Q4 		$309K Sell
11,629
-2,500
-18% -$67.8K 0.1% 55
2024
Q3 		$409K Hold
14,129
– – 0.12% 51
2024
Q2 		$395K Sell
14,129
-46
-0.3% -$1.27K 0.13% 51
2024
Q1 		$393K Hold
14,175
– – 0.14% 49
2023
Q4 		$408K Buy
+14,175
New +$429K 0.14% 53

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mirabaud & Cie's PFE Position: Q3 2025 in Review

Mirabaud & Cie sold out of Pfizer (PFE) in Q3 2025, closing a stake of 11,330 shares — an estimated $275K sold.

Mirabaud & Cie first reported a position in PFE in Q4 2023 and held it in 7 quarters. The position peaked at $409K in Q3 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Mirabaud & Cie reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Mirabaud & Cie sold 11,330 Pfizer shares in Q3 2025, an estimated $275K.
  • Mirabaud & Cie first reported a position in Pfizer in Q4 2023 and held it in 7 quarters.
  • Mirabaud & Cie's Pfizer position peaked at $409K in Q3 2024.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Mirabaud & Cie's 13F filing for Q3 2025, filed 16 Oct 2025.